Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Genuit (GEN)

Genuit Group Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:GEN
DateTimeSourceHeadlineSymbolCompany
10/06/202416:34RNS Regulatory NewsGenuit Group PLC Holding(s) in CompanyLSE:GENGenuit Group Plc
10/06/202416:32RNS Regulatory NewsGenuit Group PLC Holding(s) in CompanyLSE:GENGenuit Group Plc
28/05/202414:14RNS Regulatory NewsGenuit Group PLC Result of AGMLSE:GENGenuit Group Plc
28/05/202410:44Alliance NewsAlliance NewsGenuit revenue falls due to weak housebuilding and wet weather in UKLSE:GENGenuit Group Plc
28/05/202407:00RNS Regulatory NewsGenuit Group PLC Trading UpdateLSE:GENGenuit Group Plc
14/05/202408:00PR Newswire (US)Deepfakes, AI-Manipulated Audio, and Hijacked Social Media Surge in 2024LSE:GENGenuit Group Plc
02/05/202416:57RNS Regulatory NewsGenuit Group PLC Block listing Interim ReviewLSE:GENGenuit Group Plc
24/04/202410:39RNS Regulatory NewsGenuit Group PLC Notice of AGMLSE:GENGenuit Group Plc
10/04/202416:24RNS Regulatory NewsGenuit Group PLC Director/PDMR ShareholdingLSE:GENGenuit Group Plc
10/04/202416:17RNS Regulatory NewsGenuit Group PLC Director/PDMR ShareholdingLSE:GENGenuit Group Plc
09/04/202416:28RNS Regulatory NewsGenuit Group PLC Director DeclarationLSE:GENGenuit Group Plc
02/04/202415:56RNS Regulatory NewsGenuit Group PLC Director/PDMR ShareholdingLSE:GENGenuit Group Plc
20/03/202415:27RNS Regulatory NewsGenuit Group PLC Director/PDMR ShareholdingLSE:GENGenuit Group Plc
12/03/202410:40Alliance NewsAlliance NewsGenuit revenue drops on lower divisional sales but profit surgesLSE:GENGenuit Group Plc
12/03/202407:09Alliance NewsAlliance News*Genuit says 2024 trading has started in line w/ expectations, despite market uncertaintyLSE:GENGenuit Group Plc
12/03/202407:09Alliance NewsAlliance News*Genuit declares total dividend per share of 12.4p vs 12.3p YoYLSE:GENGenuit Group Plc
12/03/202407:07Alliance NewsAlliance News*Genuit 2023 pretax profit GBP48.4m vs GBP45.4m YoYLSE:GENGenuit Group Plc
12/03/202407:00RNS Regulatory NewsGenuit Group PLC Final ResultsLSE:GENGenuit Group Plc
01/03/202408:30RNS Regulatory NewsGenuit Group PLC Director DeclarationLSE:GENGenuit Group Plc
19/02/202409:00RNS Regulatory NewsGenuit Group PLC Notice of Results and Investor PresentationLSE:GENGenuit Group Plc
23/01/202415:49UK RegulatoryGenuit Group PLC Holding(s) in CompanyLSE:GENGenuit Group Plc
23/01/202411:24UK RegulatoryGenmab A/S Genmab Announces Net Sales Of Darzalex(R) (daratumumab) For 2023LSE:GENGenuit Group Plc
22/01/202423:40UK RegulatoryGenmab A/S Genmab Announces Decision In Arbitration Appeal Under License Agreement With JanssenLSE:GENGenuit Group Plc
09/01/202411:45UK RegulatoryGenmab A/S Tivdak(R) (tisotumab vedotin-tftv) Supplemental Biologics License Application Accepted For Priority Review By U.S. Food And Drug Administration For Patients With Recurrent Or Metastatic Cervical CancerLSE:GENGenuit Group Plc
03/01/202405:55UK RegulatoryGenmab A/S Transactions With Shares And Linked Securities In Genmab A/S Made By Managerial Employees And Their Closely Associated PersonsLSE:GENGenuit Group Plc
02/01/202414:52UK RegulatoryGenmab A/S Genmab To Present At The 42nd Annual J.P. Morgan Healthcare ConferenceLSE:GENGenuit Group Plc
12/12/202312:00UK RegulatoryGenmab A/S Genmab To Hold 2023 R&D Update And Ash Data Review MeetingLSE:GENGenuit Group Plc
09/12/202317:00UK RegulatoryGenmab A/S New Pivotal Data For Bispecific Antibody Epcoritamab (DuoBody(R) Cd3xcd20) Demonstrates High Overall And Complete Responses In Patients With Hard-To-Treat Relapsed/Refractory Follicular Lymphoma (FL)LSE:GENGenuit Group Plc
05/12/202322:26UK RegulatoryGenmab A/S Capital Increase In Genmab As A Result Of Employee Warrant ExerciseLSE:GENGenuit Group Plc
27/11/202312:00UK RegulatoryGenmab A/S Genmab Announces Positive Regulatory Updates For Epcoritamab (EPKINLY(R)/Tepkinly(R)) For The Treatment Of Relapsed/Refractory Follicular LymphomaLSE:GENGenuit Group Plc
 Showing the most relevant articles for your search:LSE:GEN